|
Mean age (SD), [range], years
|
56.3
|
(7.0)
|
[39–70]
|
|
Gender, n (%)
| | | |
|
female
|
165
|
(67.6)
|
-
|
|
male
|
79
|
(32.4)
|
-
|
|
Highest education level completed, n (%)
| | | |
|
high school
|
40
|
(16.4)
|
-
|
|
college/university
|
204
|
(83.6)
|
-
|
|
Smoking behaviour, n (%)
| | | |
|
current
|
14
|
(5.7)
|
-
|
|
never
|
127
|
(52.0)
|
-
|
|
former
|
103
|
(42.2)
|
-
|
|
Body mass index, n (%), kg/m2
| | | |
|
underweight (16.5-17.99)
|
2
|
(0.8)
|
-
|
|
normal (18–25)
|
112
|
(45.9)
|
-
|
|
overweight (25.01–29.99)
|
90
|
(36.9)
|
-
|
|
obese (30+)
|
40
|
(16.4)
|
-
|
|
Mean blood pressure (SD), [range], mm Hg
| | | |
|
systolic
|
127.0
|
(18.3)
|
[85–189]
|
|
diastolic
|
80.0
|
(11.0)
|
[55–117]
|
|
Mean low-density lipoprotein level (SD), [range], mmol/L
|
3.01
|
(0.8)
|
[1.21–5.57]
|
|
Mean high-density lipoprotein level (SD), [range], mmol/L
|
1.66
|
(0.44)
|
[.83–3.20]
|
|
Mean apolipoprotein B level (SD), [range], mmol/L
|
0.91
|
(0.24)
|
[.32–1.65]
|
|
Mean glycemia level (SD), [range], mmol/L
|
5.0
|
(0.7)
|
[3.7–10.2]
|
|
Participants reported risk factors, n (%)
| | | |
|
Hypertension
|
29
|
(11.9)
|
-
|
|
Diabetes
|
5
|
(2.0)
|
-
|
|
Medications, n (%)
| | | |
|
Anti-hypertensive medication
|
26
|
(10.7)
|
-
|
|
Hypoglycemic medication
|
2
|
(0.8)
|
-
|
